This study demonstrated that BL-8040 increased CD8+ effector T cell tumor infiltration and decreased myeloid-derived suppressor cells (MDSCs), as well as expanding the beneficial effect of chemotherapy in PDAC patients [31]. Here, CD8A is linked to neoplasm.